MADRIGAL PHARMACEUTICALS, INC. Increase (Decrease) in Accrued Liabilities
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Increase (Decrease) in Accrued Liabilities of $75.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-07-30
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $71.25M, a 113.88% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $4.29M.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$88.42M.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $187.54M, a 1118.41% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $131.90M, a 279.96% increase from fiscal 2024.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $34.72M.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$1.48M, a 104.07% decline from fiscal 2022.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $36.41M, a 270.58% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $75.54M 10-Q · filed 2026-07-30 | -$12.88M derived: sum of 3 quarters · filed 2026-07-30 | $174.66M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $4.29M 10-Q · filed 2026-05-06 | -$84.13M derived: sum of 2 quarters · filed 2026-05-06 | $103.41M derived: sum of 3 quarters · filed 2026-05-06 | $136.72M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$88.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $99.12M derived: sum of 2 quarters · filed 2026-02-19 | $132.43M derived: sum of 3 quarters · filed 2026-07-30 | $131.90M 10-K · filed 2026-02-19 | ||
| 2025-09-30 | $187.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $220.85M derived: sum of 2 quarters · filed 2026-07-30 | $220.32M 10-Q · filed 2025-11-04 | $214.01M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $33.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $32.78M 10-Q · filed 2026-07-30 | $26.48M derived: sum of 3 quarters · filed 2026-07-30 | $41.87M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | -$530.00K 10-Q · filed 2026-05-06 | -$6.84M derived: sum of 2 quarters · filed 2026-05-06 | $8.55M derived: sum of 3 quarters · filed 2026-05-06 | $31.89M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.08M derived: sum of 2 quarters · filed 2026-02-19 | $32.42M derived: sum of 3 quarters · filed 2026-02-19 | $34.72M 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $15.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $38.73M derived: sum of 2 quarters · filed 2025-11-04 | $41.02M 10-Q · filed 2025-11-04 | $48.39M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-06-30 | $23.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $25.63M 10-Q · filed 2025-08-05 | $33.00M derived: sum of 3 quarters · filed 2026-02-19 | $33.85M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-03-31 | $2.29M 10-Q · filed 2025-05-01 | $9.66M derived: sum of 2 quarters · filed 2026-02-19 | $10.51M derived: sum of 3 quarters · filed 2026-02-19 | $6.70M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2023-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $8.22M derived: sum of 2 quarters · filed 2026-02-19 | $4.41M derived: sum of 3 quarters · filed 2026-02-19 | -$1.48M 10-K · filed 2026-02-19 | ||
| 2023-09-30 | $849.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$2.96M derived: sum of 2 quarters · filed 2024-10-31 | -$8.85M 10-Q · filed 2024-10-31 | $3.01M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | -$3.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$9.70M 10-Q · filed 2024-08-07 | $2.16M derived: sum of 3 quarters · filed 2025-02-26 | $9.93M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | -$5.89M 10-Q · filed 2024-05-07 | $5.97M derived: sum of 2 quarters · filed 2025-02-26 | $13.73M derived: sum of 3 quarters · filed 2025-02-26 | $32.13M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $11.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $19.63M derived: sum of 2 quarters · filed 2025-02-26 | $38.02M derived: sum of 3 quarters · filed 2025-02-26 | $36.41M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $7.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $26.16M derived: sum of 2 quarters · filed 2023-11-06 | $24.55M 10-Q · filed 2023-11-06 | $21.10M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $18.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $16.79M 10-Q · filed 2023-08-08 | $13.34M derived: sum of 3 quarters · filed 2024-02-28 | $16.60M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | -$1.61M 10-Q · filed 2023-05-09 | -$5.06M derived: sum of 2 quarters · filed 2024-02-28 | -$1.80M derived: sum of 3 quarters · filed 2024-02-28 | $9.37M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | -$3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$192.00K derived: sum of 2 quarters · filed 2024-02-28 | $10.97M derived: sum of 3 quarters · filed 2024-02-28 | $9.83M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.43M derived: sum of 2 quarters · filed 2022-11-03 | $13.28M 10-Q · filed 2022-11-03 | $15.73M derived: sum of 4 quarters · filed 2023-03-03 | ||
| 2021-06-30 | $11.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $10.02M 10-Q · filed 2022-08-04 | $12.47M derived: sum of 3 quarters · filed 2023-03-03 | $15.29M derived: sum of 4 quarters · filed 2023-03-03 | ||
| 2021-03-31 | -$1.15M 10-Q · filed 2022-05-09 | $1.30M derived: sum of 2 quarters · filed 2023-03-03 | $4.13M derived: sum of 3 quarters · filed 2023-03-03 | $19.81M derived: sum of 4 quarters · filed 2023-03-03 | ||
| 2020-12-31 | $2.45M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-03 | $5.27M derived: sum of 2 quarters · filed 2023-03-03 | $20.95M derived: sum of 3 quarters · filed 2023-03-03 | $21.59M 10-K/A · filed 2023-03-03 | ||
| 2020-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $18.50M derived: sum of 2 quarters · filed 2021-11-04 | $19.14M 10-Q · filed 2021-11-04 | $27.50M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-30 | $15.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $16.31M 10-Q · filed 2021-08-05 | $24.67M derived: sum of 3 quarters · filed 2022-02-24 | $27.49M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-31 | $632.00K 10-Q · filed 2021-05-06 | $8.99M derived: sum of 2 quarters · filed 2022-02-24 | $11.81M derived: sum of 3 quarters · filed 2022-02-24 | $17.59M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $11.18M derived: sum of 2 quarters · filed 2022-02-24 | $16.96M derived: sum of 3 quarters · filed 2022-02-24 | $16.78M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.60M derived: sum of 2 quarters · filed 2020-11-05 | $8.42M 10-Q · filed 2020-11-05 | $8.77M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $5.61M 10-Q · filed 2020-08-06 | $5.95M derived: sum of 3 quarters · filed 2021-02-25 | $6.72M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | -$179.00K 10-Q · filed 2020-05-07 | $167.00K derived: sum of 2 quarters · filed 2021-02-25 | $930.00K derived: sum of 3 quarters · filed 2021-02-25 | $904.00K derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.11M derived: sum of 2 quarters · filed 2021-02-25 | $1.08M derived: sum of 3 quarters · filed 2021-02-25 | -$2.17M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $763.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $737.00K derived: sum of 2 quarters · filed 2019-11-06 | -$2.51M 10-Q · filed 2019-11-06 | -$1.51M derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2018-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$3.28M 10-Q · filed 2019-08-07 | -$2.27M derived: sum of 3 quarters · filed 2020-02-26 | -$303.00K derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2018-03-31 | -$3.25M 10-Q · filed 2019-05-08 | -$2.25M derived: sum of 2 quarters · filed 2020-02-26 | -$277.00K derived: sum of 3 quarters · filed 2020-02-26 | $1.75M derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.97M derived: sum of 2 quarters · filed 2020-02-26 | $5.00M derived: sum of 3 quarters · filed 2020-02-26 | $4.09M 10-K · filed 2020-02-26 | ||
| 2017-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $4.00M derived: sum of 2 quarters · filed 2018-11-06 | $3.08M 10-Q · filed 2018-11-06 | $4.37M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.11M 10-Q · filed 2018-08-07 | $2.40M derived: sum of 3 quarters · filed 2019-02-27 | -$1.58M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | -$912.00K 10-Q · filed 2018-05-08 | $371.00K derived: sum of 2 quarters · filed 2019-02-27 | -$3.61M derived: sum of 3 quarters · filed 2019-02-27 | -$3.22M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$2.69M derived: sum of 2 quarters · filed 2019-02-27 | -$2.31M derived: sum of 3 quarters · filed 2019-02-27 | -$2.28M 10-K · filed 2019-02-27 | -$2.28M 10-K · filed 2017-03-31 | |
| 2016-09-30 | -$3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$3.59M derived: sum of 2 quarters · filed 2017-11-09 | -$3.56M 10-Q · filed 2017-11-09 | -$3.56M 10-Q · filed 2016-11-14 | -$3.49M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $414.00K 10-Q · filed 2017-08-10 | $484.20K derived: sum of 3 quarters · filed 2017-08-10 | |||
| 2016-03-31 | $28.00K 10-Q · filed 2017-05-11 | $98.20K derived: sum of 2 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $70.20K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-31 | $15.20K 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | -$55.00K 10-Q/A · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |